Paper
14 June 2023 Bioactivity of mushrooms against cancer
Author Affiliations +
Abstract
Oyster mushroom has long been consumed for their delicious taste and flavour that they add to our plate. These edible herbs are also rich source of neutraceuticals that impart on it potential free radical scavenging, antioxidant, antiatherogenic, anti-tumor, immunomodulatory and anti-bacterial properties. In the present study, we deciphered the role of mushroom neutraceuticals vis a vis hallmarks of cancer via an in-silico approach. From literature survey, eleven bioactive compounds of Pleurotus ostreatus were identified e.g. Ergosterol, Rutin, β-glucan, Apigenin, Ascorbic acid, Cinnamic acid, Linoleic acid, Niacinnamide, p-coumaric acid, syringic acid and veratric acid. Molecular docking was performed taking these compounds as ligands against epidermal growth factor receptor, caspase 3 and vascular endothelial growth factor proteins, which plays important role in proliferation, apoptosis and angiogenesis of malignant cells. Our finding suggest that Rutin, Ergosterol and β-glucan has shown highest binding affinity against the three proteins and interfere in their functioning inside tumor microenvironment thereby inhibiting process of carcinogenesis and metastasis.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
M. P. Singh, Vartika Mishra, and N. B. Singh "Bioactivity of mushrooms against cancer", Proc. SPIE 12548, Smart Biomedical and Physiological Sensor Technology XX, 1254807 (14 June 2023); https://doi.org/10.1117/12.2662755
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Proteins

Cancer

Chemotherapy

In vitro testing

Molecular interactions

Molecules

Databases

Back to Top